Delivery Order SPE2DB20D3101-SPE2DB22FJ7W4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.06 firm fixed-price delivery order is for the supply of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,209.46 Firm Fixed Price Delivery Order contract is for the provision of HYSINGLA ER 20 MG TABLET 60S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,805.46 firm fixed-price delivery order is for the supply of HYSINGLA ER 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,887.98 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Hysingla ER 20 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.21 to AmerisourceBergen Drug Corp for HYSINGLA ER 20 mg tablets (60-count) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The award was made on...
- The Defense Logistics Agency awarded a delivery order valued at $1,628.83 to AmerisourceBergen Drug Corp for HYSINGLA ER 40 mg tablets (60-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,843.74 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Hysingla ER 40 mg tablets (60-count). This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed as a child contract...
- The Defense Logistics Agency awarded a $581 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561771228 Hysingla ER 60 mg tablets. As the prime contractor, Amerisourcebergen will deliver 60 count bottles of the hydrocodone bitartrate extended release tablets to a facility in Conshohocken, Pennsylvania between August 10-11, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the Agency's medical supply needs. No subcontractors or...
- The Defense Logistics Agency Troop Support Medical awarded a $233,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 bottles of 20mg Hysingla ER tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is July 12-13, 2023. No additional context was provided regarding the Defense Logistics Agency's programs or any associated contracts. The award information indicates this is a small order for a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ7W4Delivery Order
This federal contract award, valued at $1,277.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Hysingla ER 60 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/11/22 |